Literature DB >> 34506930

Non-steroidal anti-inflammatory drugs are not associated with increased risk of Clostridioides difficile infection: A propensity-score-matched case-control study.

Adam M Ressler1, Alieysa Patel2, Krishna Rao3.   

Abstract

Prior research identified an increased risk for Clostridioides difficile infection (CDI) following exposure to certain non-steroidal anti-inflammatory drugs (NSAIDs). We conducted a retrospective case-control study to evaluate the risk for CDI associated with NSAID use. NSAID use was not associated with an increased risk of CDI.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridioides difficile; NSAID; Propensity score; Risk factors

Mesh：

Substances：

Year:  2021        PMID： 34506930      PMCID： PMC8678209          DOI： 10.1016/j.anaerobe.2021.102444

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  11 in total

1.  MissForest--non-parametric missing value imputation for mixed-type data.

Authors:  Daniel J Stekhoven; Peter Bühlmann
Journal:  Bioinformatics       Date:  2011-10-28       Impact factor: 6.937

2.  Misoprostol protects mice against severe Clostridium difficile infection and promotes recovery of the gut microbiota after antibiotic perturbation.

Authors:  Joseph P Zackular; Leslie Kirk; Bruno C Trindade; Eric P Skaar; David M Aronoff
Journal:  Anaerobe       Date:  2019-06-17       Impact factor: 3.331

3.  Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.

Authors:  Q Le Bastard; G A Al-Ghalith; M Grégoire; G Chapelet; F Javaudin; E Dailly; E Batard; D Knights; E Montassier
Journal:  Aliment Pharmacol Ther       Date:  2017-12-05       Impact factor: 8.171

4.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Authors:  Peter C Austin
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

Review 5.  Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.

Authors:  Paul Eze; Evelyn Balsells; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2017-06       Impact factor: 4.413

6.  Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response.

Authors:  Damian Maseda; Joseph P Zackular; Bruno Trindade; Leslie Kirk; Jennifer Lising Roxas; Lisa M Rogers; Mary K Washington; Liping Du; Tatsuki Koyama; V K Viswanathan; Gayatri Vedantam; Patrick D Schloss; Leslie J Crofford; Eric P Skaar; David M Aronoff
Journal:  mBio       Date:  2019-01-08       Impact factor: 7.867

7.  Nonsteroidal Anti-Inflammatory Drugs Impact on the Outcomes of Hospitalized Patients with Clostridium difficile Infection.

Authors:  Harish Patel; Jasbir Makker; Trupti Vakde; Danial Shaikh; Kanthi Badipatla; James Dunne; Nikhitha Mantri; Suresh Kumar Nayudu; Mariela Glandt; Bhavna Balar; Sridhar Chilimuri
Journal:  Clin Exp Gastroenterol       Date:  2019-12-10

8.  Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.

Authors:  Anitha Menon; D Alex Perry; Jonathan Motyka; Shayna Weiner; Alexandra Standke; Aline Penkevich; Micah Keidan; Vincent B Young; Krishna Rao
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

9.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16

Review 10.  Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis.

Authors:  Nitipong Permpalung; Sikarin Upala; Anawin Sanguankeo; Suthanya Sornprom
Journal:  Can J Gastroenterol Hepatol       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.